Laura Oliphant - 16 Apr 2026 Form 4 Insider Report for AEHR TEST SYSTEMS (AEHR)

Reporting relationship
Director
Issuer ticker
AEHR
Reported as of
16 Apr 2026
Net transaction value
-$399,268
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Apr 2026, 19:14:44 UTC
Prior SEC filing
10 Apr 2026
Next SEC filing
22 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Chris Siu, Attorney-in-Fact

Key filing fact

Laura Oliphant filed Form 4 for AEHR TEST SYSTEMS (AEHR) on 16 Apr 2026.

Key facts

  • This page summarizes Laura Oliphant's Form 4 filing for AEHR TEST SYSTEMS (AEHR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Apr 2026, 19:14.

Change

  • Previous filing in this sequence was filed on 10 Apr 2026.
  • Current net transaction value: -$399,268.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001783244 Primary reporting owner

OLIPHANT LAURA

Relationship
Director
Address
C/O AEHR TEST SYSTEMS, 400 KATO TERRACE, FREMONT
Signature
/s/Chris Siu, Attorney-in-Fact
Signature date
16 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AEHR transaction

Common Stock

Sale

Transaction value
$399,268
Shares
-4,665
Change %
-100%
Price
$85.59
Shares after
0
Date
16 Apr 2026
Ownership
By Trust
AEHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
18,432
Date
16 Apr 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The amount reported includes shares subject to unvested restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .